April 24-29, 2022 | Gouvieux, France
Our team will be here to present the latest advances on in vivo/ex vivo/in vitro models and physiological measurements that can help advances your studies.
For rare diseases like DMD, ALS and other genetic disorders that impact diaphragmatic strength and cardiovascular electrophysiology, many leading research centers have come to rely on in vivo plethysmography to assess lung function, as well as advanced ECG analysis to evaluate arrhythmias.
These clinically-relevant outcomes provide deep insights into the disease pathophysiology and guide the evaluation of novel gene therapies, for instance in mdx mice, as highlighted in our article about Muscular Dystrophy.
By browsing this website, you accept the use of cookies for statistical purposes.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
